Nano-X Imaging Ltd. logo

Nano-X Imaging Ltd.

NNOX

NASDAQHealthcareMedical - Devices

Regular session

$0.8493

−$0.0106 · -1.23%

Aug 24, 12:25 PM ET

NNOX company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

55

Fair Value

Momentum

17

Strong Down

Sentiment

50

Mixed

Risk resilience

29

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.

Industry
Medical - Devices
Sector
Healthcare
Headquarters
IL
CEO
Erez I. Meltzer
Listed since
Aug 21, 2020
Employees
197

Market position

Day range

Current $0.8493

52-week range

Current $0.8493

Open
$0.8801
Previous close
$0.8599
Volume
548.63K
0.27× average
Average volume
2.04M
Average daily volume
Market cap
59.11M USD
Beta
1.27
Market reference 1
50-day average
$1.1598
-26.77% below average
200-day average
$2.2518
-62.28% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
140.11M USD
P/E (TTM)
-0.75×
P/B (TTM)
0.47×
P/S (TTM)
4.07×
EV / EBITDA
-2.86×
Earnings yield
-41.35%
Free cash flow yield
-24.81%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
-85.67%
Operating margin
-422.95%
Net margin
-523.83%
Return on equity
-53.69%
Return on assets
-46.26%
Return on invested capital
-39.69%

Financial health

Debt / equity
0.06×
Current ratio
3.96×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends401%-1468%-3337%-5206%Gross margin, FY2021: -115.95%Gross margin, FY2022: -80.21%Gross margin, FY2023: -66.55%Gross margin, FY2024: -94.03%Gross margin, FY2025: -98.21%Operating margin, FY2021: -4720.71%Operating margin, FY2022: -1278.97%Operating margin, FY2023: -631.89%Operating margin, FY2024: -502.93%Operating margin, FY2025: -466.16%Net margin, FY2021: -4739.11%Net margin, FY2022: -1226.89%Net margin, FY2023: -613.59%Net margin, FY2024: -474.31%Net margin, FY2025: -576.13%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 -115.95%. Gross margin FY2022 -80.21%. Gross margin FY2023 -66.55%. Gross margin FY2024 -94.03%. Gross margin FY2025 -98.21%. Operating margin FY2021 -4720.71%. Operating margin FY2022 -1278.97%. Operating margin FY2023 -631.89%. Operating margin FY2024 -502.93%. Operating margin FY2025 -466.16%. Net margin FY2021 -4739.11%. Net margin FY2022 -1226.89%. Net margin FY2023 -613.59%. Net margin FY2024 -474.31%. Net margin FY2025 -576.13%.

Income trends

Revenue

13.02M USD+15.40%

Operating income

−60.7M USD-6.97%

Net income

−75.02M USD-40.18%
Income trends across reported periods25.29M USD−23.8M USD−72.89M USD−121.98M USDRevenue, FY2021: 1.3M USDRevenue, FY2022: 8.58M USDRevenue, FY2023: 9.91M USDRevenue, FY2024: 11.28M USDRevenue, FY2025: 13.02M USDOperating income, FY2021: −61.56M USDOperating income, FY2022: −109.71M USDOperating income, FY2023: −62.59M USDOperating income, FY2024: −56.75M USDOperating income, FY2025: −60.7M USDNet income, FY2021: −61.8M USDNet income, FY2022: −105.24M USDNet income, FY2023: −60.78M USDNet income, FY2024: −53.52M USDNet income, FY2025: −75.02M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.3M USD. Revenue FY2022 8.58M USD. Revenue FY2023 9.91M USD. Revenue FY2024 11.28M USD. Revenue FY2025 13.02M USD. Operating income FY2021 −61.56M USD. Operating income FY2022 −109.71M USD. Operating income FY2023 −62.59M USD. Operating income FY2024 −56.75M USD. Operating income FY2025 −60.7M USD. Net income FY2021 −61.8M USD. Net income FY2022 −105.24M USD. Net income FY2023 −60.78M USD. Net income FY2024 −53.52M USD. Net income FY2025 −75.02M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue13.02M USD11.28M USD9.91M USD8.58M USD1.3M USD
Cost of goods sold25.81M USD21.89M USD16.5M USD15.46M USD2.82M USD
Gross profit−12.79M USD−10.61M USD−6.59M USD−6.88M USD−1.51M USD
Research and development19.24M USD20.18M USD26.05M USD26.51M USD17.12M USD
Selling, general, and administrative27.1M USD25.75M USD28.39M USD45.63M USD41.74M USD
Operating expenses47.91M USD46.14M USD56M USD72.33M USD60.05M USD
Interest income1.42M USD2.87M USD1.65M USD789K USD
Interest expense288K USD
Depreciation and amortization11.7M USD11.73M USD11.81M USD11.51M USD2.29M USD
Operating income−60.7M USD−56.75M USD−62.59M USD−109.71M USD−61.56M USD
Net income−75.02M USD−53.52M USD−60.78M USD−105.24M USD−61.8M USD

Company facts updated Aug 24, 2026.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

6 ratings
Strong buy00%
Buy467%
Hold233%
Sell00%
Strong sell00%

NNOX peers

ETFs holding NNOX

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research NNOX

research.disclaimer